N/A
Completed N=203
The Impact of Vitamin D on Tuberculosis Among Koreans
Source: ClinicalTrials.gov NCT01137370 ↗Enrolled (actual)
203
Serious AEs
—
Results posted
Feb 2014
Primary outcomePrimary: Prevalence of Vitamin D Deficiency — 36.2; 27.3 participants, %
Summary
Vitamin D has been regarded to be beneficial to tuberculosis (TB) patients. The aim of this study is to elucidate the role of vitamin D deficiency in development and treatment outcomes among Korean TB patients. Furthermore, the impact of genotypes of vitamin D receptor gene on TB development will also be evaluated.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Prevalence of Vitamin D Deficiency |
36.2; 27.3 | — |
| PRIMARY Median 25-OHD Level |
— | — |
Eligibility Criteria
Inclusion Criteria
- older than 19 years
- diagnosed and treated having a tuberculosis
Exclusion Criteria
- positive HIV antibody
Data sourced from ClinicalTrials.gov (NCT01137370). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.